EKF Diagnostics (LON:EKF – Get Free Report) released its quarterly earnings data on Tuesday. The company reported GBX 0.54 earnings per share for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 4.86% and a return on equity of 3.58%.
EKF Diagnostics Price Performance
EKF stock traded up GBX 0.56 during mid-day trading on Thursday, reaching GBX 25.56. 355,551 shares of the company’s stock were exchanged, compared to its average volume of 326,592. The company has a debt-to-equity ratio of 2.09, a current ratio of 4.72 and a quick ratio of 1.77. EKF Diagnostics has a 12-month low of GBX 22 and a 12-month high of GBX 31.70. The stock’s 50 day moving average is GBX 25.43 and its 200 day moving average is GBX 25.51. The company has a market cap of £109.44 million, a price-to-earnings ratio of 54.38 and a beta of 0.50.
EKF Diagnostics Company Profile
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Recommended Stories
- Five stocks we like better than EKF Diagnostics
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
